Boca Raton, United States
IoTech International, Inc., founded in 2013, positions itself at the forefront of molecular iodine research and development. As a world leader in this niche, the company leverages a unique, stable, and patented technology to enhance active molecular iodine concentrations by over 100-fold, a significant breakthrough in iodine chemistry—the first of its kind in 65 years.
Under the scientific leadership of Director Rodger Kolsky and Dr. Jack Kessler, this biotechnology firm delivers revolutionary health solutions tailored for professionals in the Biotechnology, Health Care, and Life Sciences sectors. Their product offerings span flavored oral rinses, periodontal gels, concentrated irrigating solutions, hand cleansers, and nasal mists, all capitalizing on the transformational efficacy of molecular iodine.
Headquartered in the United States, IoTech International last received a $50.00K Seed Round investment in June 2015. Without any specified investors from that round, the company now seeks further investment to accelerate its growth and industry impact.
